The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

In Europe, meanwhile, Regeneron’s PD-1 inhibitor Libtayo (cemiplimab) is indicated as a second-line therapy for recurrent or advanced cervical cancer, regardless of PD-L1 expression status, ...

Many types of immunotherapy are being tested in clinical trials, and some are used to treat cervical cancer ... Cemiplimab (Libtayo) also targets PD-1. It can be given to patients with advanced vulvar ...

The Teal Wand is an at-home vaginal sample self-collection device that tests for HPV. The test will first be available in ...

At-home screenings are effective alternatives for closing the screening gap. One study found that mailing kits to people ...

To get screened for cervical cancer, patients in the United States may no longer need to put their feet in those awkward ...

Teal Health has made an at-home test that screens for human papillomavirus (HPV), the virus that causes nearly all cervical cancers.

For the first time, the FDA has just approved a device that lets people screen for cervical cancer from home. Known as the ...

Teal Health, the maker of an at-home cervical cancer screening test, says it will give patients an alternative to in-clinic pap smears.

And thanks to a company called Teal Health, that desire may soon be granted: Its at-home, self-collect cervical cancer screening device was approved by the FDA on May 9. It involves running the ...

The U.S. Food and Drug Administration has approved the first at-home test for cervical cancer screening, its maker Teal ...

The U.S. Food and Drug Administration on Friday approved Teal Health to provide the nation's first at-home test kit to screen for cervical cancer.